Who
Amy Elazzouzi
SVP, Finance & PAO
Company insider
Files Form 4 as: SVP, Finance & PAO, Aura Biosciences.
In numbers
- Trades disclosed
- 34
- Buys
- 0
- Sells
- 8
- Bought
- $0
- Sold
- $189K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Oct 2024
- Last trade
- 1 Sep 2026
- Last filed
- 1 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Sep 2026filed 1 Sep 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —23,540 at $0.00 | filing |
| 1 Sep 2026filed 1 Sep 2026 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —46,460 at $0.00 | filing |
| 1 Sep 2026filed 1 Sep 2026 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —46,460 at $0.00 | filing |
| 1 Sep 2026filed 1 Sep 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —23,540 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —44,528 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,472 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,472 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —44,528 at $0.00 | filing |
| 17 Feb 2026filed 17 Feb 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Sold | $43K8,549 at $5.06 | filing |
| 17 Feb 2026filed 17 Feb 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Sold | $43K8,549 at $5.06 | filing |
| 20 Jan 2026filed 20 Jan 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Sold | $7,6841,581 at $4.86 | filing |
| 20 Jan 2026filed 20 Jan 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Sold | $7,6841,581 at $4.86 | filing |
| 29 Oct 2025filed 29 Oct 2025 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Sold | $5,690896 at $6.35 | filing |
| 18 Aug 2025filed 18 Aug 2025 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,554 at $0.00 | filing |
| 18 Aug 2025filed 18 Aug 2025 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,094 at $0.00 | filing |
| 18 Aug 2025filed 18 Aug 2025 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —547 at $0.00 | filing |
| 18 Aug 2025filed 18 Aug 2025 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —547 at $0.00 | filing |
| 18 Aug 2025filed 18 Aug 2025 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,744 at $0.00 | filing |
| 18 Aug 2025filed 18 Aug 2025 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,094 at $0.00 | filing |
| 18 Aug 2025filed 18 Aug 2025 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,319 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.